New Type II Diabetes Medication TRADJENTA Approved
_244x183.jpg)
People with Type II Diabetes have a new treatment option with the approval of Tradjenta,a new once daily oral tablet. "This approval provides another treatment option for the millions of Americans with type 2 diabetes," said Mary Parks, MD, director of the FDA's division of metabolism and endocrinology products. "It is effective when used alone or when added to existing treatment regimens."
In the same class as Januvia and Onglyza, Tradjenta comes in only ONE strength (5mg) and can be taken with other diabetes medications, like Glucophage (Metformin), Glimepiride (Amaryl), and Pioglitazone (Actos).The drug is used in combination with diet and exercise and has been proven to be safe and effective in Type II Diabetics.
